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Dear Editor, 
Recently, I read an article entitled "Literature Review on IMRT and VMAT for Prostate Cancer" 
published by American Journal of Cancer Review in its Volume 2, Issue 1[1]. Authors have done excellent 
work in reviewing two radiation treatment techniques for prostate cancer, and the article also highlights 
various factors which can have direct or indirect impact on the dosimetric results. Prostate cancer is the 
most frequently diagnosed cancer among men in the world. Different types of treatment options are 
currently available to manage the prostate cancer, and radiation therapy is one of them. Due to advancement 
in computing power and technology, it is now possible to generate very conformal dose plans for the 
prostate cancer. Although VMAT provides slight advantage over the IMRT,  the superiority of the VMAT 
over the IMRT is still a debating topic due to lack of clinical evidence [1].  
In the review article [1], authors have focused solely on the IMRT and VMAT, which use photon 
radiation beams to deliver the radiation dose. However, there are other radiotherapy techniques, which can 
produce comparable results to that of IMRT and VMAT. The primary purpose of this letter is to provide 
brief update on the most advanced radiotherapy technique in the form of proton therapy for the prostate 
cancer. Proton therapy can produce excellent dose distribution because protons have finite range and sharp 
distal fall-off at the end of proton beam path [2]. Several studies [3-10] have shown that proton therapy is 
capable of producing excellent dosimetric results in terms of rectal and bladder sparing. For example, 
Vargas et al. [3] demonstrated that proton therapy is better at sparing rectum and bladder when compared to 
photon therapy. Trofimov et al. [4] showed that the angled lateral proton fields can further reduce the rectal 
dose. Rana et al. [5] showed that the combination of lateral and oblique fields in proton therapy provides 
dosimetric advantage over the VMAT for prostate cancer involving a metallic hip prosthesis. Chera et al.[6] 
showed that proton therapy reduced the dose to the bladder, rectum, small bowel, and pelvis when 
compared to the IMRT. In another study by Rana et al. [7], it was shown that the proton therapy produced 
lower values for the rectum and bladder doses for the similar target volume coverage when compared to the 
VMAT. Hence, literature review indicates that the advanced proton therapy technique has the potential of 
lowering rectal and bladder toxicities in prostate cancer patients when compared to the photon therapy such 
as IMRT and VMAT.  
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